is semaglutide good for fatty liver Therapeutic Effects of on Nonalcoholic Disease with Type 2 Diabetes Mellitus and Obesity: An Open-Label Controlled Trial The weight-loss-independent hepatoprotective benefits of

Gut microbiota regulates mouse behaviors through glucocorticoid receptor pathway genes in the hippocampus

Ipamorelin is the ghrelin-side trigger

The Alluvi Research Pen has been developed to support laboratories seeking a convenient and consistent alternative to conventional peptide preparation

The SELECT trial [3] (N=17,604, NEJM 2023) demonstrated that these effects extend beyond weight loss to 20% cardiovascular risk reduction over 4 years

Among cancers, liver cancer and pancreatic cancer show the strongest association

This suggests that some therapeutic benefits of canagliflozin could result from the activation of AMPK, rather than inhibition of SGLT2 ( DPP-4 inhibitors These compounds, by preventing deactivation by dipeptidyl peptidase-4 (DPP4) inhibitors, improve the concentration of endogenous incretins (Vangoitsenhoven et al., 2012)